Drug intelligence / Profile preview

echium amoenum + rheum ribes

Development stage
Unknown
Lead developer
Mashhad University of Medical Sciences
Modality
Small Molecules
Administration
Oral
01

Overview

echium amoenum + rheum ribes is an investigational herbal combination therapy formulated as an oral syrup for the treatment of obsessive-compulsive disorder (OCD). The combination consists of extracts from *Echium amoenum* L. (commonly known as Iranian Borage) and *Rheum ribes* (Syrian Rhubarb). In clinical evaluations, specifically a triple-blind, randomized, controlled trial (IRCT20200712048088N1), the syrup demonstrated efficacy in reducing the severity of OCD symptoms as measured by the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) over an 8-week period. While the exact mechanism of action is not fully defined, the therapeutic effects are thought to be mediated by the synergistic action of phytochemicals—such as flavonoids and rosmarinic acid—on central nervous system pathways, potentially involving serotonergic modulation. The treatment has been reported as safe with no significant adverse effects compared to placebo.

Other names
Echium amoenum and Rheum ribes syrupEchium amoenum + Rheum ribes herbal combination

Beyond the preview

Go deeper on echium amoenum + rheum ribes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on echium amoenum + rheum ribes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call